177Lu-edotreotide is a type of therapy known as peptide receptor radionuclide therapy (PRRT). It is used to treat certain types of tumors that have specific receptors on their surface. This therapy involves using a radioactive substance that targets and binds to these receptors, allowing the radiation to directly affect the tumor cells. The goal is to slow down or stop the growth of the tumor by damaging the cancer cells with radiation.

Everolimus is a medication that works by blocking a specific protein in the body that helps cancer cells grow. It is used to treat various types of tumors by slowing down their growth and spread. Everolimus is taken orally and helps to control the disease by interfering with the cancer cells’ ability to multiply. This medication is often used when other treatments have not been effective.

Neuroendocrine Tumors of the Lung and Thymus – Neuroendocrine tumors of the lung and thymus are a group of rare tumors that originate from neuroendocrine cells, which have traits similar to nerve cells and hormone-producing cells. These tumors can vary in their growth rate and are classified based on their differentiation, with well to moderately differentiated tumors being less aggressive. As they progress, these tumors may grow slowly and can spread to other parts of the body, although the rate of progression can vary significantly among individuals. Symptoms often arise from the tumor’s location and may include coughing, chest pain, or difficulty breathing if located in the lung, or pressure symptoms if in the thymus. Hormonal symptoms can also occur if the tumor secretes hormones. The progression of these tumors is monitored through imaging and clinical evaluation to assess changes in size and spread.